ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2022 | $19,815 | +23.8% | 972 | +17.8% | 0.00% | – |
| Q3 2022 | $16,000 | 0.0% | 825 | +0.5% | 0.00% | – |
| Q2 2022 | $16,000 | -65.2% | 821 | -47.6% | 0.00% | – |
| Q1 2022 | $46,000 | -11.5% | 1,568 | -30.1% | 0.00% | – |
| Q4 2021 | $52,000 | -23.5% | 2,244 | +2.7% | 0.00% | – |
| Q3 2021 | $68,000 | +1600.0% | 2,184 | +2151.5% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 97 | +12.8% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 86 | +75.5% | 0.00% | – |
| Q4 2020 | $2,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |